Needham Reiterates Buy on Alkermes, Maintains $62 Price Target

Needham analyst Ami Fadia has reiterated a Buy rating on Alkermes (NASDAQ: ALKS) and maintained a price target of $62 for the company's stock. This endorsement reflects confidence in Alkermes' performance and potential in the market.